Kathleen Beusterien, MPH
Kathleen is Principal, RWE at Cerner Enviza, an Oracle Company. She has over 25 years of experience performing health outcomes research. Kathleen has consulted on a number of communications with the FDA and EMA regarding patient reported outcomes (PRO) endpoints in clinical trials and has developed PRO measures and dossiers for regulatory review. She has numerous preference and PRO publications and regularly leads workshops and presentations at scientific and industry conferences on these areas. She is a founding member of the International Academy of Health Preference Research (IAHPR).